Distribution of nuchal translucency thickness at 11 to 14 weeks of gestation in a normal Turkish population

Distribution of nuchal translucency thickness at 11 to 14 weeks of gestation in a normal Turkish population

Background/aim: The aim of this study was to determine fetal nuchal translucency (NT) thickness nomogram values in first trimester in a Turkish population and compare them with previously reported European and Asian nomogram data. Material and methods: Ultrasonographic measurements of crown-rump length (CRL) and NT thicknesses were obtained from 11 to 14 weeks of gestation in a normal Turkish population. Pregnant women with singleton pregnancy and fetal CRL between 45 and 84 mm were included in the study. The mean 1st, 3rd, 5th, 50th, 90th, 95th, 97th, and 99th percentiles and fixed cut off values of ≥ 2.5 mm, ≥ 3 mm, ≥ 3.5 mm NT thicknesses for a CRL between 45 and 84 mm were determined. Results: A total of 1605 healthy fetuses were enrolled in the study. The sonographic measurements were performed on 1541 (%94) fetuses transabdominally and on 99 cases (%4) by the transvaginal route. The mean NT thickness for CRL between 45 and 84 mm was 1.57 ± 074 mm, and the mean 95th, 97th, and 99th percentiles of these values were 2.82 mm, 3.17, and 4.75 mm, respectively. The incidence of NT thicknesses at fixed points of ≥ 2.5 mm, ≥ 3 mm, and ≥ 3.5 mm in normal fetuses were 6.7%, 4.1%, and 2.1%, respectively. Conclusion: The present study demonstrated the nomogram data of fetal NT thickness in a Turkish population. We think that this report will be useful for further research related to NT thickness values on the prenatal diagnosis for the first trimester chromosomal abnormalities in Turkish populations.Key words: Nuchal translucency, ultrasonography, first trimester, crown-rump length, ethnic origin

___

  • 1. Nicolaides KH, Heath V, Cicero S. Increased fetal nuchal translucency at 11-14 weeks. Prenatal Diagnosis 2002; 22(4): 308-315.
  • 2. Bronshtein M, Zimmer EZ, Blazer S. The utility of detailed first trimester ultrasound examination in abnormal fetal nuchal translucency. Prenatal Diagnosis 2008; 28(11): 1037-1041. doi: 10.1002/pd.2119
  • 3. Miltoft CB, Ekelund CK, Hansen BM, Lando A, Petersen OB et al. Increased nuchal translucency, normal karyotype and infant development. Ultrasound Obstetrics & Gynecology 2012; 39: 28-33. doi: 10.1002/uog.10060
  • 4. Kagan KO, Avgidou K, Molina FS, Gajewska K, Nicolaides KH. Relation between increased fetal nuchal translucency thickness and chromosomal defects. Obstetrics & Gynecology 2006; 107 (1):6-10.
  • 5. Bindra R, Heath V, Liao A, Spencer K, Nicolaides KH. One-stop clinic form assessment of risk for trisomy 21 at 11-14 weeks: a prospective study of 15 030 pregnancies. Ultrasound Obstetrics & Gynecology 2002; 20 (3): 219-225.
  • 6. Thilaganathan B, Khare M, Williams B, Wathen NC. Influence of ethnic origin on nuchal translucency screening for Down’s syndrome. Ultrasound Obstetrics & Gynecology 1998; 12:112- 114. doi: 10.1046/j.1469-0705.1998.12020112-x
  • 7. Chen M, Lam YH, Tang MH, Lee CP, Sin SY et al. The effect of ethnic origin on nuchal translucency at 10-14 weeks of gestation. Prenatal Diagnosis 2002; 22 (7): 576-578. doi: 10.1002/pd.363
  • 8. Artunc-Ulkumen B, Pala HG, Uyar Y, Bulbul-Baytur Y, Koyuncu FM. Normal range of intracranial translucency in healthy Turkish pregnancies and its association with first trimester maternal serum biochemistry and ductus venosus pulsatility index. Ginekologia Polska 2014; 85: 738-741.
  • 9. Nicolaides KH, Azar G, Byrne D, Mansur C, Marks K. Fetal nuchal translucency: ultrasound screening for chromosomal defects in first trimester of pregnancy. British Medical Journal 1992;304(6831):867-869. doi: 10.1136/bmj.304.6831.867
  • 10. Ratha C and Khurana A. First things first: images for a proper nuchal translucency in the first trimester 11–13+6 weeks scan. Journal of Fetal Medicine 2014; 1: 55-57. doi: 10.1007/s40556- 014-0015-x
  • 11. Kor-Anantakul O, Suntharasaj T, Suwanrath C, Chanprapaph P, Sirichotiyakul S et al. Distribution of normal nuchal translucency thickness: a multicenter study in Thailand. Gynecologic and Obstetric Investigation 2011; 71(2): 124-128. doi: 10.1159/000320754
  • 12. Jou HJ, Wu SC, Li TC, Hsu HC, Tzeng CY et al. Relationship between fetal nuchal translucency and crown-rump length in an Asian population. Ultrasound Obstetrics & Gynecology 2001; 17(2): 111-114. doi: 10.1046/j.1469-0705.2001.00332.x
  • 13. Chung JH, Yang JH, Song MJ, Cho JY, Lee YH et al. The distribution of fetal nuchal translucency thickness in normal Korean fetuses. Journal of Korean Medical Science 2004; 19 (1): 32-36.
  • 14. Hasegawa J, Nakamura M, Hamada S, Matsuoka R, Ichizuka Ket al. Distribution of nuchal translucency thickness in Japanese fetuses. Journal of Obstetrics and Gynaecology Research 2013; 39 (4): 766-769. doi: 10.1111/j.1447-0756.2012.02037. x
  • 15. Hellmuth SG, Pedersen LH, Miltoft CB, Petersen OB, Kjaergaard S et al. Increased nuchal translucency thickness and risk of neurodevelopmental disorders. Ultrasound Obstetrics & Gynecology 2017; 49(5): 592-598. doi: 10.1002/uog.15961
  • 16. Pandya PP, Snijders RJ, Johnson SP, De Lourdes Brizot M, Nicolaides KH. Screening for fetal trisomies by maternal age and fetal nuchal translucency thickness at 10 to 14 weeks of gestation. British Journal of Obstetrics and Gynecology 1995; 102:957-962. doi: 10.1111/j.1471-0528. 1995.tb10902.x
  • 17. Maya I, Yacobson S, Kahana S, Yeshaya J, Tenne T et al. Cutoff value of nuchal translucency as indication for chromosomal microarray analysis. Ultrasound Obstetrics & Gynecology 2017; 50(3): 332-335. doi: 10.1002/uog.17421
  • 18. Senat MV, Bussières L, Couderc S, Roume J, Rozenberg P et al. Long-term outcome of children born after a first-trimester measurement of nuchal translucency at the 99th percentile or greater with normal karyotype: a prospective study. American Journal of Obstetrics & Gynecology 2007; 196(1): 53. doi: 10.1016/j.ajog.2006.08.026
Turkish Journal of Medical Sciences-Cover
  • ISSN: 1300-0144
  • Yayın Aralığı: Yılda 6 Sayı
  • Yayıncı: TÜBİTAK
Sayıdaki Diğer Makaleler

The prognostic value of serum levels of a proliferation-inducing ligand (APRIL) in treatment-naïve patients with chronic lymphocytic leukemia

Muhlis Cem AR, Teoman SOYSAL, Ayşe SALİHOĞLU, Hafize UZUN, Zafer BAŞLAR, Tuğrul ELVERDİ, Ahmet Emre EŞKAZAN, Şeniz ÖNGÖREN, Sinem Nihal ESATOĞLU, Dilek KESKİN, Yıldız AYDIN

Hepatitis A susceptibility parallels high COVID-19 mortality

Fatma Burcu BELEN, Kadir Mutlu HAYRAN, Faik SARIALİOĞLU

Nontraumatic coma in the pediatric intensive care unit: etiology, clinical characteristics and outcome

Muhterem DUYU, Selin YILDIZ, Zeynep KARAKAYA

Diagnostic efficacy of apparent diffusion coefficient measurements in differentiation of malignant intra-axial brain tumors

İlker EYÜBOĞLU, Serdar ASLAN, İsmet Miraç ÇAKIR, Ahmet SARI

Projecting the course of COVID-19 in Turkey: A probabilistic modeling approach

Seher Nur SÜLKÜ, Aybar C. ACAR, Hüseyin Cahit BURDUROĞLU, Yeşim AYDIN SON, Levent AKIN, Serhat ÜNAL, Ahmet Görkem ER

Can urinary biomarkers predict acute kidney injury in newborns with critical congenital heart disease?

Eser SÖZMEN, Mehmet YALAZ, Özgün UYGUR, Özge ALTUN KÖROĞLU, Nilgün KÜLTÜRSAY, Yüksel ATAY, Mete AKISÜ, Ertürk LEVENT, Fırat ERGİN

Impaired integrity of commissural and association fibers in essential tremor patients: Evidence from a diffusion tensor imaging study

Aygül TANTİK PAK, Alpay ALKAN, Yıldızhan ŞENGÜL, Hafize OTCU

Evaluating the Persian versions of two psoriatic arthritis screening questionnaires early arthritis for psoriatic patients questionnaire (EARP) and psoriasis epidemiology screening tool (PEST) in Iranian psoriatic patients

Vahide LAJEVARDI, Zahra GHODSI, Mahdieh SHAFIEI, Amir TEIMOURPOUR, Ifa ETESAMI

IgE-mediated food allergy throughout life

Ebru ÇELEBİOĞLU, Ayşegül AKARSU

Do initial hematologic indices predict the severity of COVID-19 patients?

Nizameddin KOCA, Yasemin ÜSTÜNDAĞ, Abdullah ŞİMŞEK, Hülya PARILDAR, Kağan HUYSAL, Ali ASAN, Burcu Dalyan CİLO, Halil Erkan SAYAN